Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China

WIXOM, Mich., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency...
January 05, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Present at H.C. Wainwright BioConnect 2021 Conference

WIXOM, Mich., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
December 16, 2020 07:00 ET | Source: Rockwell Medical, Inc.

Industry Veteran Andrea Heslin Smiley joins Rockwell Medical’s Board of Directors

WIXOM, Mich., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
November 09, 2020 16:05 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Provides Third Quarter 2020 Financial and Operational Update

-Ended the quarter with $67.3 million in cash, cash equivalents and investments- -Q3 2020 revenue of $15.3 million- -U.S. commercial launch of Triferic® AVNU expected in Q1 2021- -Poised to enroll...
October 27, 2020 08:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical to Report Third Quarter 2020 Financial and Operating Results on November 9, 2020

WIXOM, Mich., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
October 13, 2020 08:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Announces Presentations at the American Society of Nephrology Virtual Kidney Week 2020

WIXOM, Mich., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
September 24, 2020 18:09 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Growth Plan and New Therapeutic Opportunities for Its Ferric Pyrophosphate Citrate (FPC) Platform

-New indications for FPC platform provide significant growth opportunity- -Anticipates Type C meeting with FDA for home infusion in Q1 2021 and for acute heart failure in 2H 2021- ...
September 23, 2020 08:45 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces $35.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

WIXOM, Mich., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
September 15, 2020 07:59 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Appointment of Russell L. Skibsted as Executive Vice President, Chief Financial Officer and Chief Business Officer

WIXOM, Mich., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
September 09, 2020 16:15 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Enters into Exclusive License Agreement with Jeil Pharmaceutical Co., Ltd., for the Rights to Commercialize Triferic® in South Korea

WIXOM, Mich., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...